S Venkateswaran, L Pari, P Viswanathan, VP Menon
Index: J. Ethnopharmacol. 57(3) , 161-7, (1997)
Full Text: HTML
Livex, a compound herbal formulation, was investigated for its possible hepatoprotective effect in Wistar rats against erythromycin estolate induced toxicity. Oral administration of Livex significantly prevented the occurrence of erythromycin estolate induced hepatic damage. The increased level of serum enzymes (aspartate transaminase, alanine transaminase, alkaline phosphatase), bilirubin, serum and tissue cholesterol, triglycerides, phospholipids and free fatty acids observed in rats treated with erythromycin estolate were very much reduced in rats treated with Livex and erythromycin estolate. These biochemical observations were supplemented by histopathological examination of liver sections. Results of this study revealed that Livex could afford a significant protection against erythromycin estolate induced hepatocellular damage.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Erythromycin Estolate
CAS:3521-62-8 |
C52H97NO18S |
Preparation and characterization of biodegradable poly(l-lac...
2004-03-15 [J. Colloid. Interface Sci. 271(2) , 336-41, (2004)] |
Pharmacokinetics of erythromycin estolate and erythromycin p...
2000-08-01 [Am. J. Vet. Res. 61(8) , 914-9, (2000)] |
Five days of erythromycin estolate versus ten days of penici...
1996-09-01 [Eur. J. Clin. Microbiol. Infect. Dis. 15(9) , 712-7, (1996)] |
Pharmacokinetics of erythromycin after the administration of...
2008-12-01 [J. Vet. Pharmacol. Ther. 31(6) , 496-500, (2008)] |
Multicenter, randomized, double-blind comparison of erythrom...
1998-07-01 [Eur. J. Clin. Microbiol. Infect. Dis. 17(7) , 470-8, (1998)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved